Synapse

← The Lancet Regional Health - Europe

Papers in The Lancet Regional Health - Europe

Page 14 · newest first

  1. Climate change and mental health: direct, indirect, and intersectional effectsThe Lancet Regional Health - Europe · 2024
  2. Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective Finnish AntiCoagulation in Atrial Fibrillation (FinACAF) cohortThe Lancet Regional Health - Europe · 2024
  3. Adoption of high-sensitivity cardiac troponin for risk stratification of patients with suspected myocardial infarction: a multicentre cohort studyThe Lancet Regional Health - Europe · 2024
  4. Survival among people with HIV and their families in Denmark 1995–2021: a nationwide population-based cohort studyThe Lancet Regional Health - Europe · 2024
  5. In-hospital mortality, comorbidities, and costs of one million mechanically ventilated patients in Germany: a nationwide observational study before, during, and after the COVID-19 pandemicThe Lancet Regional Health - Europe · 2024
  6. Implications of food ultra-processing on cardiovascular risk considering plant origin foods: an analysis of the UK Biobank cohortThe Lancet Regional Health - Europe · 2024
  7. The dark side of light: light at night may raise the risk of type 2 diabetesThe Lancet Regional Health - Europe · 2024
  8. Fleeting victories: COVID-19 and the temporary improvements in asthma care behavioursThe Lancet Regional Health - Europe · 2024
  9. Personal light exposure patterns and incidence of type 2 diabetes: analysis of 13 million hours of light sensor data and 670,000 person-years of prospective observationThe Lancet Regional Health - Europe · 2024
  10. Why is it so difficult to implement precision psychiatry into clinical care?The Lancet Regional Health - Europe · 2024
  11. How to assess whether a complex intervention for chronic conditions is cost-effective?The Lancet Regional Health - Europe · 2024
  12. Utility of ultrasound in the diagnostic work-up of suspected pulmonary embolism: an open-label multicentre randomized controlled trial (the PRIME study)The Lancet Regional Health - Europe · 2024
  13. Narrative change for inclusionary health and migration policiesThe Lancet Regional Health - Europe · 2024
  14. Discriminatory, racist and xenophobic policies and practice against child refugees, asylum seekers and undocumented migrants in European health systemsThe Lancet Regional Health - Europe · 2024
  15. Priority setting and migration health policies for European countriesThe Lancet Regional Health - Europe · 2024
  16. Strengthening life-course immunisation in migrant populations: access, equity, and inclusionThe Lancet Regional Health - Europe · 2024
  17. Universal health coverage for undocumented migrants in the WHO European region: a long way to goThe Lancet Regional Health - Europe · 2024
  18. Migrant-sensitive healthcare in Europe: advancing health equity through accessibility, acceptability, quality, and trustThe Lancet Regional Health - Europe · 2024
  19. Capacity building in migration and health in higher education: lessons from five European countriesThe Lancet Regional Health - Europe · 2024
  20. Normalising participatory health research approaches in the WHO European region for refugee and migrant health: a paradigm shiftThe Lancet Regional Health - Europe · 2024
  21. Smartphone application versus written material for smoking reduction and cessation in individuals undergoing low-dose computed tomography (LDCT) screening for lung cancer: a phase II open-label randomised controlled trialThe Lancet Regional Health - Europe · 2024
  22. Challenges in monitoring the quality of care in multiple sclerosisThe Lancet Regional Health - Europe · 2024
  23. Institutional betrayal in the face of a collective national trauma in IsraelThe Lancet Regional Health - Europe · 2024
  24. Modifiable risk factors for asthma exacerbations during the COVID-19 pandemic: a population-based repeated cross-sectional study using the Research and Surveillance Centre primary care databaseThe Lancet Regional Health - Europe · 2024
  25. Political economy dichotomy in primary health care: bridging the gap between reality and necessityThe Lancet Regional Health - Europe · 2024
  26. Input precision, output excellence: the importance of data quality control and method selection in disease risk mappingThe Lancet Regional Health - Europe · 2024
  27. Trends in vaping and smoking following the rise of disposable e-cigarettes: a repeat cross-sectional study in England between 2016 and 2023The Lancet Regional Health - Europe · 2024
  28. Impact of single round of low dose CT lung cancer screening on cause of mortality in different socio-economic groups: a post-hoc analysis of long-term follow-up of the UKLS trialThe Lancet Regional Health - Europe · 2024
  29. Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort studyThe Lancet Regional Health - Europe · 2024
  30. Changes in behavior and biomarkers during the diagnostic decision period for COVID-19, influenza, and group A streptococcus (GAS): a two-year prospective cohort study in IsraelThe Lancet Regional Health - Europe · 2024
  31. Overcoming barriers to cervical screening attendance among underrepresented populations in EuropeThe Lancet Regional Health - Europe · 2024
  32. Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the NetherlandsThe Lancet Regional Health - Europe · 2024
  33. Morbidity and mortality among children, adolescents, and young adults with cancer over six decades: a Swedish population-based cohort study (the Rebuc study)The Lancet Regional Health - Europe · 2024
  34. Maternal, prenatal and postnatal risk factors for early child physical abuse: a French nationwide cohort studyThe Lancet Regional Health - Europe · 2024
  35. Germany's cannabis act: a catalyst for European drug policy reform?SHILAP Revista de lepidopterología · 2024
  36. Cost-effectiveness of the children and young People's health partnership (CYPHP) model of integrated care versus enhanced usual care: analysis of a pragmatic cluster randomised controlled trial in South LondonThe Lancet Regional Health - Europe · 2024
  37. Lanreotide versus placebo for tumour reduction in patients with a 68Ga-DOTATATE PET-positive, clinically non-functioning pituitary macroadenoma (GALANT study): a randomised, multicentre, phase 3 trial with blinded outcome assessmentThe Lancet Regional Health - Europe · 2024
  38. Air pollution and myocardial infarction in PolandThe Lancet Regional Health - Europe · 2024
  39. Association between changes in cardiovascular health and the risk of multimorbidity: community-based cohort studies in the UK and FinlandThe Lancet Regional Health - Europe · 2024
  40. Announcing The Lancet Regional Health-Europe commission on inequalities and disparities in cardiovascular healthThe Lancet Regional Health - Europe · 2024
  41. Diagnosis of common health conditions among autistic adults in the UK: evidence from a matched cohort studyThe Lancet Regional Health - Europe · 2024
  42. Utilization of colorectal cancer screening tests across European countries: a cross-sectional analysis of the European health interview survey 2018–2020The Lancet Regional Health - Europe · 2024
  43. Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study)The Lancet Regional Health - Europe · 2024
  44. Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankThe Lancet Regional Health - Europe · 2024
  45. Trends in cause-specific mortality among people with type 2 and type 1 diabetes from 2002 to 2019: a Danish population-based studyThe Lancet Regional Health - Europe · 2024
  46. Risks of second primary cancers among 584,965 female and male breast cancer survivors in England: a 25-year retrospective cohort studyThe Lancet Regional Health - Europe · 2024
  47. Parental psychiatric diagnoses as predictive factors for autism spectrum disorder in the child: confluence of genetics and environmentThe Lancet Regional Health - Europe · 2024
  48. Impact of long COVID on health-related quality-of-life: an OpenSAFELY population cohort study using patient-reported outcome measures (OpenPROMPT)The Lancet Regional Health - Europe · 2024
  49. Association between parental psychiatric disorders and risk of offspring autism spectrum disorder: a Swedish and Finnish population-based cohort studyThe Lancet Regional Health - Europe · 2024
  50. European congress of psychiatry (EPA) 2024The Lancet Regional Health - Europe · 2024